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Abstract
Background—Flight attendants may have elevated breast cancer incidence (BCI). We evaluated 
BCI’s association with cosmic radiation dose and circadian rhythm disruption among 6,093 female 
former U.S. flight attendants.
Methods—We collected questionnaire data on BCI and risk factors for breast cancer from 2002–
2005. We conducted analyses to evaluate (i) BCI in the cohort compared to the U.S. population; 
and (ii) exposure-response relations. We applied an indirect adjustment to estimate whether parity 
and age at first birth (AFB) differences between the cohort and U.S. population could explain BCI 
that differed from expectation.
Results—BCI was elevated but may be explained by lower parity and older AFB in the cohort 
than among U.S. women. BCI was not associated with exposure metrics in the cohort overall. 
Significant positive associations with both were observed only among women with parity of three 
or more.
Conclusions—Future cohort analyses may be informative on the role of these occupational 
exposures and non-occupational risk factors.
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INTRODUCTION
Flight attendants may be at an increased risk of breast cancer due to workplace exposures, 
including cosmic radiation and circadian rhythm disruption from traveling across multiple 
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time zones [Sigurdson and Ron, 2004; IARC, 2010]. Recently published studies of flight 
attendants and other airline crew populations [Pinkerton et al., 2012; Hammer et al., 2014] 
have not found elevated risk of breast cancer mortality among flight attendants, nor have 
they found exposure-related increases in risk. However, mortality studies have limitations 
for breast cancer etiologic research, given the high survival rates from breast cancer [e.g., 5-
year survival was 89–91% from 2000–2004; Howlader et al., 2013]. In addition, records-
based mortality studies rarely supply detailed information on important covariates for breast 
cancer, such as parity, age at first birth, or family history of breast cancer. Earlier cancer 
incidence studies of airline crew [e.g., Pukkala et al., 1995], summarized in Sigurdson and 
Ron [2004]; found increased risks of breast cancer in flight attendants that were not fully 
explained by available data on reproductive risk factors. A cancer incidence study conducted 
in a pooled cohort of Scandinavian airplane cabin crew [Pukkala et al., 2012] found a 50% 
increased incidence rate of breast cancer compared to the general public. In a nested case-
control study that adjusted for parity and age at first birth, breast cancer was not found to be 
related to exposure to cosmic radiation or to number of flights with many time zone 
crossings, a metric of potential circadian rhythm disruption.
In this study, we present findings from a cancer incidence study conducted in a large U.S. 
cohort of female flight attendants, for which a previous mortality report did not find 
increased breast cancer risk [Pinkerton et al., 2012], to determine whether the cohort is at 
increased risk of incident breast and other cancers and whether risk is associated with flying-
related cosmic radiation dose or to measures of circadian rhythm disruption. This 
questionnaire-based cohort represents one of the few among flight attendants to have 
information on important risk factors for breast cancer, such as reproductive history and 
family history of breast cancer. This manuscript represents the first report of cancer 
incidence in this cohort compared to the general U.S. population, and evaluates simple 
exposure-response associations for breast cancer in stratified analyses that consider family 
history and some reproductive risk factors (i.e., parity and age at first birth).
MATERIALS AND METHODS
This study was conducted under the review and approval of the Institutional Review Boards 
of the National Institute for Occupational Safety and Health and the National Cancer 
Institute [2014]. Informed consent to participate in the study was obtained from all 
participants (or their next of kin for those who had proxy respondents).
Cohort Description
The incidence cohort for this study is a subset of the mortality cohort of former flight 
attendants employed by Pan American World Airways (Pan Am) that was described in detail 
in Pinkerton et al. [2012]. It was assembled from the personnel records of Pan Am, which 
were available for employees who left employment in 1953 or later. It included employees 
(male and female) who were employed for at least one year as a flight attendant before Pan 
Am ceased operation in 1991, were U.S. citizens when they were hired, and who worked at 
least one day after January 1, 1953 (n = 11,324). In 1981, Pan Am acquired National 
Airlines. For cohort members who subsequently transferred to Pan Am (n = 1393), the time 
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employed as a flight attendant at National Airlines was included in establishing the one year 
minimum employment criterion for eligibility.
Of the 9617 women in the mortality cohort, 105 were considered ineligible for the incidence 
study because their last known address was outside the United States. The remaining living 
female flight attendants in the mortality cohort were invited to participate in the incidence 
cohort by completing a detailed telephone or mailed questionnaire (administered between 
August 2002 and July 2005), which contained questions about their demographic 
information, work history, and non-occupational risk factors for breast cancer (e.g., 
reproductive history and use of alcohol, tobacco, and hormone replacement therapy). For 
deceased flight attendants, we attempted to contact next-of-kin, who were invited to 
complete the questionnaire about the decedent. Repeated attempts were made by telephone 
and mail to contact all non-respondents.
The incidence cohort includes all the telephone interview and mailed questionnaire 
respondents (n = 6177), with three exceptions: (i) mailed questionnaire respondents who did 
not return a signed consent form or who withdrew consent to participate in the study (n = 
33); (ii) women with initially unknown citizenship who indicated they were not U.S. citizens 
in a screening question (n = 49); and (iii) women who were diagnosed with a breast cancer 
before entry into the cohort (n = 2). The latter two groups were considered ineligible. Thus, 
the incidence cohort available for analysis includes 6093 women (64.4% of the 9461 eligible 
women in the mortality cohort). This includes 134 proxy respondents in the survey for 
decedents or cohort members who were incapable of responding, with the proxies 
distributed as follows: 62 spouses; 11 daughters; 7 sons; 21 sisters; 11 mothers; 22 others.
Questionnaire Data
The questionnaire administered to living participants is provided in the online supplement. 
Because the present analysis compares the incidence of breast cancer in the cohort to that in 
the general population, with adjustment for key factors such as parity, age at first birth, and 
family history of breast cancer, we focus here on these covariates in our description of the 
handling of questionnaire data.
In this analysis, the non-exposure-related covariates of interest were age, calendar period, 
race, parity, age at first birth, and family history of breast cancer. The latter three were 
selected out of all potential covariates because they are strong risk factors for breast cancer, 
their various categories had relatively high prevalence in the cohort, and they have been 
shown to be potential effect modifiers in studies of ionizing radiation and breast cancer risk 
[Ronckers et al., 2005]. Parity and age at first birth were also selected because we 
anticipated that their distribution would be substantially different in the cohort than in the 
U.S. population. The methods by which we obtained data on these variables and how we 
treated them for analysis are described in online supplemental material.
Breast Cancer Case Ascertainment
Eligible breast cancer cases occurred between the start of follow-up for each cohort member 
(detailed in the “Statistical analyses” section below) and the questionnaire administration 
date. To identify incident breast cancers, we first obtained self (or proxy) report of a cancer 
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in the questionnaire. We then conducted medical record follow-back of each reported cancer 
case by contacting the physician’s office, hospital, or other health care organization in which 
the cancer diagnosis was made and obtaining supporting documentation of the diagnosis. 
Self (or proxy) reported breast cancers that were refuted by a review of the medical records 
were not included, but we included reported cancers that were neither confirmed nor refuted. 
We also linked the incidence cohort to cancer registries in six states (California, Florida, 
New York, Texas, Virginia, and Washington), based on the locations of the domiciles for 
the airline and on common states of residence for the cohort. Eighty-two percent of breast 
cancer cases in the cohort were verified using medical record follow-back and/or cancer 
registry linkage. Seven breast cancer cases (primarily carcinoma in situ) were identified 
solely by registry linkage. We searched death certificates for all decedents but identified no 
breast cancers that were not found via the questionnaire.
All cancer diagnoses obtained from the questionnaire or medical record follow-back were 
coded using the International Classification of Diseases revision in effect at the time of 
diagnosis. Breast cancer cases were identified based on ICD-8 and -9 code 174, and ICD-10 
code C50 (malignant neoplasm of breast) and on ICD-8 code 233, ICD-9 code 233.0, and 
ICD-10 code D05 (carcinoma in situ of breast). For cancer registry data, diagnoses were 
available from ICD-O-3 codes for site, behavior, and histology. Breast cancer cases were 
identified using behavior code 3 and site code C50.0–C50.9. We also included carcinoma in 
situ of breast (behavior code 2 and site code C50.0–C50.9). No cases of breast neoplasm of 
uncertain behavior were identified in the cohort. For the statistical analyses, we used only 
the first diagnosis of a breast cancer for each cohort member. Date of diagnosis was 
obtained preferentially from medical records, then registry data, then self (or proxy) reported 
age (choosing the midpoint of the age year) for the first reported breast cancer.
Exposure Assessment
We used self-reported work history data to estimate duration of employment for every 
cohort member except those who did not provide work history data (n = 195, which includes 
proxies). For the latter group, we used work history records from Pan Am and (in some 
instances) National Airlines to estimate employment duration. We estimated cosmic 
radiation dose for each self-respondent based on her occupational dose received during work 
flights and during commuter flights (taken to the domicile to which the flight attendant was 
assigned), as described in detail in Anderson et al. [2011]. Briefly, questionnaire data 
consisted of airline of employment, assigned domicile, start/end dates of employment at the 
domicile, number of block hours (flight time plus taxi time) worked per month, and number 
of commuter flights flown per month. These data were combined with domicile-and/or era-
specific dose rates to estimate daily absorbed dose from occupational exposure to cosmic 
radiation. The cosmic radiation dose is expressed as absorbed dose in mGy (i.e., no radiation 
or tissue weighting factor applied).
The quality of the questionnaire data regarding circadian rhythm disruption was poor for 
some respondents, so we calculated the cumulative number of time zones crossed and time 
spent working as a flight attendant during the standard sleep interval using algorithms 
described elsewhere [Grajewski et al., 2003; Waters et al., 2009].
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Complete work history questionnaire data were available for 99% of living women in the 
incidence cohort, and data on commuter travel were available for 98%. For cohort members 
(including proxy respondents) with no self-reported work history data (n = 195), cosmic 
radiation dose, time zones crossed, and travel in the standard sleep interval were estimated 
using the methods of Waters et al. [2009] in combination with work history information 
obtained from Pan Am records.
The cosmic radiation dose and circadian rhythm disruption exposure metrics incorporate 
exposure incurred during all employment as a flight attendant at Pan Am and National and 
(for self-respondents) exposure during commuter flights and from flight attendant jobs at 
other airlines, but not exposure from air travel associated with non-flight attendant jobs or 
personal air travel.
Statistical Analyses
Statistical analyses were conducted using the NIOSH Life Table Analysis System for 
Windows [LTAS.NET; Schubauer-Berigan et al., 2011] to compare the incidence of breast 
cancer in the cohort to the incidence of breast cancer that would be expected based on 
comparison to the U.S. population. All analyses were planned a priori. The U.S. general 
population rates were estimated based on data from the National Cancer Institute’s 
Surveillance, Epidemiology, and End Results (SEER) population for the period 1970–2005. 
SEER represents cancer diagnosis and population data for a non-randomly selected 28% of 
the U.S. population [NCI, 2014]. Data are more representative for urban areas and for races 
other than white and for those of Hispanic ethnicity. The rate numerator was based on the 
combination of invasive female breast cancer (ICD-10 code C50) and in situ breast 
neoplasms (ICD-10 code D05), which were recoded from ICD-O-3 data in the same way as 
for the cohort. The SEER rate file included the number of new cases of female breast cancer 
(i.e., both first and subsequent primaries) as the numerator and the total female population 
(i.e., including prevalent cases) as the denominator. While the numerator can be adjusted to 
include the first primary cancer only, the number of prevalent cases is unknown and (for 
early years) can be only estimated based on data from the Connecticut Tumor Registry, 
which began in 1935. Because uncertainty is inherent in rates adjusting for prevalent cases, 
we chose to use unadjusted rate denominators. In this situation, overall error is minimized 
and the SIR is not overestimated by retaining second or subsequent primary breast cancers 
in the rate numerator [Merrill and Feuer, 1996]. The rate file was stratified by race (white, 
all other races), age (15–19, 20–24, …, 80–84, 85 +), and calendar year (1970–74, 1975–79, 
…, 2000–04, 2005).
Time-dependent variables were used for covariates that could change through the period of 
follow-up and for which temporal information was available (e.g., parity, age at first birth), 
as well as for the main exposure variables of interest (cosmic radiation dose, number of time 
zones crossed, and time spent working during the standard sleep interval).
Person-time at risk for each cohort member began on the latest of the following dates: (i) 
January 1, 1970 (the date the SEER rate file begins); (ii) the date the one year employment 
eligibility period was met; or (iii) (for flight attendants who transferred to Pan Am from 
National) the date of transfer to Pan Am. Person-time at risk ended at the earliest date 
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among the following events (i) first diagnosis of breast neoplasm; (ii) death; and (iii) 
interview or questionnaire completion.
Person-time was stratified by the LTAS.NET program into age and calendar time strata and 
then multiplied by the appropriate race-specific breast cancer rates for women to calculate 
the expected number of breast cancer cases, which were summed across all strata. The ratio 
of observed to expected number of breast cancer cases was expressed as the standardized 
incidence ratio (SIR). Ninety-five percent confidence intervals (CI) were computed for the 
SIRs assuming a Poisson distribution for observed cases. The exact Poisson distribution was 
used for number observed less than 11; otherwise, Byar’s approximation was used [Breslow 
and Day, 1987].
We evaluated SIRs for the overall cohort and for each potential confounder (race, family 
history of breast cancer, parity, and age at first birth). SIRs for breast cancer were also 
stratified by each exposure variable (cumulative absorbed cosmic dose, cumulative number 
of time zones crossed, and cumulative time spent working during the standard sleep 
interval), divided into quintiles based on the exposure distribution among cases. For the 
primary analyses, we applied a 10-year lag period to the exposure metrics, to account for a 
delay between exposure and the diagnosis of breast cancer. A 10-year lag is consistent with 
the National Academies’ recommendations [National Academy of Sciences (NAS), 1990] 
and recent breast cancer incidence studies among Nordic flight crew [e.g., Kojo et al., 2005; 
Pukkala et al., 2012]. We evaluated alternative lags (5, 15, and 20 years) in a sensitivity 
analysis.
We calculated standardized rate ratios (SRRs) to compare female breast cancer among 
cohort members in higher exposure categories with those in the lowest exposure category for 
each 10-year lagged exposure metric, adjusting for age, race, and calendar year. A linear 
trend test for the directly standardized rates was calculated in LTAS.NET using weighted 
least squares regression with weights estimated from the Poisson variance of the cancer 
counts; statistical significance of each trend was determined using a two-tailed Z-test with α 
= 0.05 [Rothman, 1986; Schubauer-Berigan et al., 2011].
Analyses were also conducted for each 10-year lagged exposure variable, stratifying on 
parity (0, 1, 2, 3 +), age at first birth category (<25, 25–<30, 30–<35, 35 +), or family 
history of breast cancer in a first degree relative, in addition to the standard stratification 
variables of race, age, and calendar time. These analyses excluded women for whom parity, 
age at first birth, or family history of breast cancer was unknown. A parity-, age-at-first-
birth-, or family history-adjusted pooled slope value was calculated (weighted by the inverse 
of the variance of the stratum-specific slope estimates) if the estimates were not found to 
vary substantially by strata (i.e., no substantial effect modification).
We used indirect adjustment [Axelson and Steenland, 1988] to evaluate the impact on the 
breast cancer SIR of differences in parity and age at first birth (separately) in the cohort, 
compared to the female U.S. population. For parity, we assumed that parity was the only 
reason the Pan Am cohort had an elevated risk of breast cancer and estimated the cohort’s 
expected breast cancer incidence rate using the fraction in each parity group and known 
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breast cancer rate ratios compared to uniparous women (from Ewertz et al. [1990], adapted 
slightly to account for different parity cutpoints used in that study compared to ours): 1.30 
for nulliparity, 1 for uniparity, 0.92 for parity of 2, and 0.70 for parity of 3 or more. We 
compared this rate to the expected breast cancer incidence rate in the female U.S. population 
estimated using analogous fractions of the U.S. population (obtained as a weighted mean of 
birth cohorts 1943, 1947, and 1953 from Hamilton and Cosgrove [2010]) and the same 
breast cancer rate ratios. The two estimated rates were divided to obtain an estimate of the 
bias factor (i.e., the amount of confounding produced by differences in the parity 
distributions). The estimated bias in the breast cancer SIR due to differences in parity was 
calculated as the quotient of this ratio in the cohort and that in the female U.S. population. 
We estimated a bias-adjusted 95% CI by dividing the lower and upper bounds of the cohort 
CI by the bias factor, which should produce an interval that is at least as wide as the true 
bias-adjusted CI.
We calculated an indirect adjustment for age at first birth using similar methods, obtaining 
U.S. population data on this metric from Kirmeyer and Hamilton [2011] (averaging the 
closest available birth cohorts, which were 1935 and 1960), and relative risks for age at first 
birth of 3% for each year of delay past age 20 from Parkin [2011]. For the age at first birth 
analysis, we assumed that the percentage of parous women was the same in the cohort and 
the U.S. population, because data on age at first birth for the latter excluded nulliparous 
women and we wanted to evaluate the effects of parity and age at first birth independently.
RESULTS
The flight attendant cohort characteristics are described in Table I. Cohort members had a 
median year of birth of 1947, and breast cancer cases were born on average three years 
earlier. Only 2% of the cohort overall and 8% of the breast cancer cases were deceased. 
More than 90% of the cohort and of breast cancer cases were white. A family history of 
breast cancer was reported by 14% of the cohort and 21% of cases. The distribution of parity 
was similar among cases and the general cohort, but a slightly higher percentage of cases 
had an age at first birth of 25–29 and a slightly lower percentage had age at first birth of 30–
34. Cumulative exposure metrics (including employment duration, absorbed radiation dose, 
time zones crossed, and hours spent flying during the standard sleep interval) were all 
slightly lower, but with wide variability, among cases than among the cohort. Correlations 
among all four cumulative exposure metrics were very high (Spearman ρ ranged from 0.94 
to 0.99).
We observed 344 first primary breast cancers in the cohort. For the LTAS analyses, 
beginning follow-up in 1970 (the rate file begin date) eliminated one woman (a breast 
cancer case) from the cohort; thus, the total number of breast cancers included in this 
analysis was 343, with an accrual of 162,477 woman-years. The overall incidence of breast 
cancer in the cohort was 37% higher (95% CI: 23%, 52%) than in the U.S. population, 
adjusting for race, age and calendar year (Table II). Nulliparous and uniparous women had 
similar SIRs compared to the general population, at about the overall cohort value. Women 
with parity of two had a nearly 60% higher breast cancer rate than the general population, 
and those with higher parity had an SIR of near unity. Among parous women, those who 
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first gave birth before age 25 did not exhibit an elevated SIR, while women who first gave 
birth at older ages exhibited significantly elevated breast cancer rates (34% to 56% higher) 
compared to the general population (Table II).
The Pan Am cohort had much lower parity (Fig. 1) and older age at first birth (Fig. 2) than 
U.S. women of similar birth cohorts. The indirect adjustment for the differences in parity 
and age at first birth gave a parity-adjusted overall SIR of 1.19 (95% CI: 1.07, 1.32) and an 
age-at-first-birth-adjusted SIR of 1.17 (95% CI: 1.05, 1.30). If parity and age at first birth act 
independently (leading to multiplicative independent effects), the adjusted SIR for both 
would be 1.02 (95% CI: 0.92, 1.13).
In 10-year lagged analyses, cumulative cosmic radiation exposure, hours spent flying during 
the standard sleep internal, time zones crossed, and employment duration all showed SIRs 
that did not vary substantially across exposure groups (Table III). Internal comparisons 
showed that in no higher exposure group did any of these exposure metrics show elevated 
SRRs compared to the lowest exposure groups. The trend slope was non-significantly 
negative for each cumulative exposure metric (Table III). In sensitivity analyses, changing 
the exposure lag did not affect these results (Appendix Tables A1–A3).
The exposure-response slopes for the four workplace exposure variables stratified by family 
history are shown in Table IV. There were no substantive differences in the slopes (i.e., in 
their direction or statistical significance) by family history (indicating little important effect 
modification), and the pooled slope estimate was similar to the unadjusted slope estimate 
(indicating little confounding by family history).
The exposure-response slopes for the occupational exposure metrics stratified by parity are 
shown in Table V. Nulliparous women had non-significantly negative breast cancer 
incidence trends for absorbed radiation dose, time zones crossed, and employment duration 
and a non-significantly positive trend for hours spent in the standard sleep interval. 
Uniparous women showed significant negative trends (P <0.01) for absorbed dose and time 
zones crossed, and non-significantly negative trends for the other exposure metrics. Women 
with parity of two or greater showed positive trends in breast cancer incidence with each 
exposure metric, although only absorbed dose, hours spent flying in the standard sleep 
interval, and number of time zones crossed among women with parity of three or more were 
statistically significant (P <0.05).
Stratification of exposure metrics by age at first birth (among parous women) gave slopes 
that were consistently negative for women with age at first birth of 30 or greater, although 
few were statistically significant (Table VI). All exposure measures showed a substantially 
(and usually significantly) increased SIR and SRR in the highest exposure category for the 
parous women who gave birth younger than age 25 (data not shown). Women who first gave 
birth younger than age 30 had positive slopes for absorbed radiation dose (non-statistically 
significant) and time zones crossed (statistically significant only for the youngest age at first 
birth category). A non-significant positive trend was observed for hours spent traveling 
during the standard sleep interval among women who first gave birth between age 25 and 
29. The slopes for employment duration were consistently negative among all age at first 
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birth categories, although only statistically significant for the oldest group. The pooled 
estimate for employment duration slope across age-at-first-birth strata was of different 
direction than the unadjusted slope, indicating substantial confounding.
DISCUSSION
In this study, we observed that female flight attendants employed at Pan American World 
Airways in 1953 or later exhibited a 37% increased risk of age-, race-, and calendar-year-
adjusted breast cancer (95% CI: 23–52%) compared to the U.S. population. This elevated 
risk was not explained by any of the workplace exposure metrics, including cosmic radiation 
and the two variables used to characterize potential circadian rhythm disruption: number of 
flight hours during the standard sleep interval, and number of time zones crossed during 
flying. The most likely explanation for the higher risk of breast cancer among this cohort is 
the difference in reproductive risk factors compared to the general population. The Pan Am 
flight attendants’ cohort had far lower parity, on average, than U.S. women in the same birth 
cohorts (Fig. 1) and a later age at first birth (Fig. 2). The indirect adjustments that were 
conducted for the independent effects of parity and age at first birth suggest that these two 
factors in combination could have explained the excess risk that was observed in the Pan 
Am cohort. Research on other cohorts [e.g., Ewertz et al., 1990; Kelsey et al., 1993] 
suggests that the effects of these two reproductive risk factors are independent. A relatively 
high percentage of the cohort (14%) reported a family history of breast cancer. This estimate 
is similar to recent estimates from the Nurses’ Health Study [12.8%; Yaghjyan et al., 2012] 
and population-based studies in the United States [e.g., 10.9%; Mai et al., 2010] and may 
reflect increasing breast cancer diagnoses over time among U.S. women.
Our lack of observed association between occupational exposures and breast cancer 
incidence is consistent with most published studies of flight attendants. An early, small case-
control study [Rafnsson et al., 2001] found a significant four-fold elevation in breast cancer 
risk among flight attendants hired after 1971, when doses among young flight attendants 
were presumed to be highest. Based on the prevalence of reproductive factors in the general 
population and flight attendants, those authors concluded that parity and age at first birth did 
not explain the increase in risk compared to the general population. However, they did not 
observe differences in parity and age at first birth compared to the general population as 
large as were observed in our study. A study of flight crew in Sweden [Linnersjö et al., 
2003] found a 30% increased breast cancer risk compared to the general population, but it 
was not related to duration of employment, and differences in parity and age at first birth did 
not seem to fully explain the excess. In a nested case-control study [Linnersjö et al., 2003], 
breast cancer incidence was higher among those with over 5000 block hours of high-
altitude, long-distance flights, but this was based on a small number of cases and the result 
was uncertain and not statistically significant. Another small nested case-control study [Kojo 
et al., 2005] found a positive association between self-reported sleep rhythm disruption and 
breast cancer incidence, but confidence intervals were very wide. They observed no 
association with cosmic radiation. A more comprehensive pooled study among air crew in 
four Nordic countries [Pukkala et al., 2012], of comparable size to our study, found a 
significant 50% elevation in breast cancer risk compared to the general population. The 
authors saw no association between cosmic radiation or the number of flights crossing six or 
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more time zones and breast cancer risk. They did not estimate the percentage of the 
elevation that was due to differences in parity and age at first birth in the cohort and the 
general population; however, they also concluded that none of the known risk factors for 
breast cancer, including parity and age at first birth, seemed to explain the excess.
For a small percentage of the Pan Am cohort (the 15% who had three or more live or still 
births), a significant positive trend was observed for cosmic radiation and the two circadian 
rhythm disruption metrics. It is unclear why this group would exhibit greater sensitivity to 
the effects of cosmic radiation or circadian rhythm disruption than women with lower parity. 
The sensitivity of the breast to radiation and other exogenous (and endogenous) agents is 
thought to be lessened after the breast cell differentiation that occurs following first and 
subsequent births [Colditz et al., 2006]. Other research suggests breast cancer risk from 
ionizing radiation is lower for those with high parity and young age at first birth [Land et al., 
1994; Ronckers et al., 2005]. Thus, our finding seems suspect for cosmic radiation. 
However, flight attendants have reported much higher rates of disrupted sleep in cross-
sectional surveys, as compared to the general population [McNeely et al., 2014]. It is 
possible that circadian rhythm disruption could also be affected by the spacing of multiple 
births and parity. A recent study showed that the frequency of reported sleep insufficiency 
among U.S. women increases linearly with the number of children in the home [Chapman et 
al., 2012]. It is possible that our subgroup of high-parity cohort members, already sleep-
stressed from the home environment, was more sensitive to the effects of occupational 
circadian rhythm disruption. To our knowledge, this is the first time that risks of 
occupational exposures among flight crew have been stratified by parity and age at first 
birth.
Studies of other shift workers (such as military employees and nurses) have observed a 
significant trend of increased risk of breast cancer with duration of night shift work among 
women; however, these studies did not evaluate effect modification by parity or age at first 
birth [Lie et al., 2006; Schernhammer et al., 2006; Hansen and Lassen, 2012]. Furthermore, 
most of these studies observed associations with shift work and breast cancer only after very 
long durations of shift work employment. We could not evaluate whether the circadian 
rhythm disruption metrics were associated with breast cancer risk among long-term workers 
(e.g., those who worked for longer than the cohort median of 7.7 years) because no cases 
occurred in the low-exposure groups among these long-term workers, due to the strong 
correlation between employment duration and exposure.
Strengths
This cohort of female Pan Am flight attendants, with over 6000 participants and 344 breast 
cancer cases, is among the largest in which a questionnaire-based incidence study has been 
conducted. Its large size and long follow-up period make it potentially highly informative on 
the association between cosmic radiation or circadian rhythm disruption metrics and breast 
cancer. This is the first study to evaluate work at night, although the ability to uniquely 
evaluate the effect of this metric was limited by its high correlation with other exposure 
metrics. Additional strengths include its use of questionnaire data to obtain information on 
other risk factors for breast cancer (to be explored in future analyses), as well as medical 
Schubauer-Berigan et al. Page 10
Am J Ind Med. Author manuscript; available in PMC 2015 October 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
record follow-back and registry linkage for verification of diagnosis. We also had a high 
response rate for individual questions on the questionnaire, reducing the need to rely on 
imputation for missing data. Although questionnaire data were collected retrospectively 
(with respect to breast cancer diagnosis), the occupational exposure metrics other than self-
reported duration of employment as a flight attendant (which corresponded well with 
workplace records) were developed using objective external sources [Anderson et al., 2011], 
by researchers who were blinded to case status.
Limitations
The follow-up end date was 2005 or earlier for all cohort members, and it is unknown 
whether the results we observed over the studied time period are representative of current 
levels of breast cancer risk in this cohort. The incidence cohort had a response rate of only 
64% after repeated contact attempts by telephone and mail. The response rate (e.g., by 
proxies) was lower among decedents (41%) in the mortality study than among living cohort 
members (65%). Among breast cancer decedents, the response rate was similarly low, at 
46%. The impact of low response rate on the generalizability of our observed results is 
uncertain. However, median duration of Pan Am employment (based on workplace records) 
among the respondents (5.8 years) was slightly longer than for the mortality cohort (5.0 
years), suggesting that long-term employees of Pan Am were more likely to respond to the 
questionnaire.
This cohort of flight attendants had low estimated cumulative cosmic radiation absorbed 
dose (7.5 mGy was the median dose) and narrow exposure distribution (90% of the 
incidence cohort had dose between 1 and 34 mGy), which limits the ability to detect a 
significant dose-response association. Contrary to previous studies that used estimated 
effective dose [e.g., Pinkerton et al., 2012; Pukkala et al., 2012], we used units of absorbed 
dose that do not incorporate a “quality factor” (Q) or radiation weighting factor that 
accounts for the greater relative biological effectiveness (RBE) of high-linear energy 
transfer radiation. In part, this was because the recently recommended weights for proton 
and neutron radiations are reduced compared to weights used in previous studies. For 
example, the International Commission on Radiological Protection [2003], in its most recent 
guidance, advocates the use of an RBE of 2 for protons and 6 for the combination of 
neutrons of different energies resulting from cosmic radiation [ICRP, 2003, p. 80]. Because 
about 50% of the dose equivalent [ICRU, 2010] or 13–25% of absorbed dose [e.g., 
Anderson et al., 2011] of cosmic radiation under commercial aviation conditions is from 
neutrons, while the largest contribution is from photons, electrons, and positrons (i.e., low-
linear-energy-transfer radiation), the overall RBE of cosmic radiation would be expected to 
be still lower. This is supported by recent studies of empirical microdosimetry for total 
cosmic radiation on board actual aircraft at a range of altitudes and latitudes, which suggest 
values of Q for total cosmic radiation of approximately 2–2.5 [Meier and Hubiak, 2010; 
Burda et al., 2013]. The attenuated Q was thought to be due partially to shielding of 
occupants (from low-energy neutrons) provided by the aircraft, fuel, and cargo [Ferrari et 
al., 2005; Burda et al., 2013]. The impact of a low RBE for cosmic radiation is the 
persistence of the limitation in power of air crew studies to be informative on risk of low-
dose radiation exposure.
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An additional limitation is that the four primary occupational exposure metrics (employment 
duration, cosmic radiation dose, number of time zones crossed, and number of hours spent 
flying during the standard sleep interval) are all highly correlated, which complicates the 
interpretation of positive findings. The correlation between the first three metrics was noted 
to be very high in the mortality analysis of this cohort [Spearman ρ of 0.96–0.99; Pinkerton 
et al., 2012]. This high correlation persists in the incidence cohort and is equally high for the 
standard sleep interval metric. As noted in the mortality study, this high correlation derives 
from the tendency for long-haul flights (which confer the highest cosmic radiation dose) to 
cross multiple time zones and to overlap the standard sleep interval of 10 pm–8 am. All 
three metrics are obviously also closely related to duration of employment as a flight 
attendant. Furthermore, because we did not have individual flight records for each cohort 
member, there was likely to be misclassification in exposure estimates. Neither the airline 
nor the flight attendants kept records of individual flight histories, and so the radiation and 
time-zone metrics may be quite markedly in error. However, such exposure misclassification 
will probably introduce Berksonian error into assessments of exposure for both metrics. As 
such this will not (to first order) bias the regression estimates, although it will inflate their 
variances [Carroll et al., 2006]. The available flight data (domicile-specific averages applied 
to each individual) likely contributed to the high correlation between metrics and affected 
our ability to detect an association with breast cancer incidence. However, it should be noted 
that a more individualized exposure assessment approach used in a recent study of airline 
pilots for whom lifetime records of flights were available [Grajewski et al., 2011] also found 
that cumulative cosmic radiation dose was highly correlated with cumulative time zones 
crossed (Spearman ρ = 0.91–0.92), though not as highly with employment duration 
(Spearman ρ = 0.66). For flight attendants, it is very unlikely that individualized lifetime 
flight records could be reconstructed because such data are not retained either by the airlines 
or by the flight attendants themselves.
Another limitation is that we used a population rate file with “prevalent cases” included in 
the denominator and “second primaries” included in the numerator, which has been found to 
increase population rates by 3.5% [Merrill and Feuer, 1996]. This would lead to a slight 
underestimate in our SIRs for breast cancer. The small group of women (n = 38) in the 
cohort who indicated they were multiracial (with white as one of the races) were classified 
differently than in the cancer incidence rate file. However, this limitation is unlikely to have 
influenced these findings, given the small number of affected women. Lastly, in this 
analysis, we did not adjust for all reproductive (and other) risk factors simultaneously in 
regression models of the association between cosmic radiation or circadian rhythm 
disruption metrics and breast cancer incidence, although little evidence of confounding was 
seen for the metrics evaluated. Future analyses of this cohort, which focus on internal 
comparisons through Cox regression modeling, are being conducted to address this 
limitation and to consider a wider range of potential confounders and effect modifiers.
CONCLUSIONS
This large study of breast cancer incidence in a cohort of U.S. flight attendants formerly 
employed at Pan Am found increased risk compared to the general population; however, 
breast cancer incidence was not related to cosmic radiation or to two metrics of circadian 
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rhythm disruption in the overall cohort. The excess risk in the cohort compared to the U.S. 
population appeared to be largely explained by differences in parity and age at first birth, 
which were lower and later (respectively) in the Pan Am cohort. However, an association of 
one or more of the occupational exposure metrics with breast cancer risk cannot be ruled out 
for the small subgroup of women with parity of 3 or more or age at first birth below 25. We 
recommend that additional research be carried out in populations with extensive shift work 
exposure to determine whether this finding is observed elsewhere.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Appendix
TABLE AI
Five-year Lagged Results for Exposure-related Variables, Using Quintile Cutpoints for Each 
Metrica
Analysis description N cases PY SIR
95% CI 
on SIR SRR
95% CI 
on SRR Trend slope (SE), P
Absorbed dose (mGy) 2.35E-05b(9.09E-06), 0.0097
 0 to <1.79 68 48,701 1.37 1.07, 1.74 1.0 —
 1.79 to <4.04 70 35,688 1.33 1.04, 1.68 0.98 0.68, 1.41
 4.04 to <8.12 67 31,901 1.45 1.12, 1.84 1.04 0.72, 1.49
 8.12 to <16.0 70 28,710 1.37 1.07, 1.73 1.08 0.75, 1.56
 16.0+ 68 17,477 1.34 1.04, 1.70 1.54 0.57, 4.13
SSI travel (hours) −8.02E-08 (1.04E-07), 0.44
 0 to <395 68 56,625 1.15 0.89, 1.46 1.0
 395 to <873 69 31,394 1.52 1.18, 1.92 1.30 0.92, 1.86
 873 to <1585 69 26,247 1.76 1.37, 2.23 1.52 1.06, 2.17
 1585 to <2996 69 28,588 1.30 1.01, 1.64 1.26 0.88, 1.80
 2996+ 68 19,623 1.28 0.99, 1.62 0.95 0.67, 1.35
Time zones crossed 
(n)
−2.88E-08 (2.41E-08), 0.23
 0 to <933.9 69 52,838 1.21 0.94, 1.54 1.0 —
 933.9 to <1902 69 30,270 1.56 1.22, 1.98 1.24 0.86, 1.77
 1902 to <3740 68 31,195 1.51 1.17, 1.92 1.22 0.85, 1.76
 3740 to <7998 70 31,619 1.23 0.96, 1.56 1.16 0.80, 1.68
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Analysis description N cases PY SIR
95% CI 
on SIR SRR
95% CI 
on SRR Trend slope (SE), P
 7998+ 67 16,555 1.41 1.09, 1.79 0.94 0.65, 1.36
Empl. duration (days) −3.70E-08 (1.88E-08)b, 0.049
 0 to <853 68 51,313 1.37 1.06, 1.74 1.0
 853 to <1829 69 36,417 1.30 1.01, 1.65 0.97 0.68, 1.39
 1829 to <3229 68 29,256 1.52 1.18, 1.93 1.13 0.79, 1.61
 3229 to <6659 71 31,797 1.20 0.93, 1.51 0.97 0.67, 1.38
 6659+ 67 13,694 1.54 1.19, 1.95 0.85 0.60, 1.22
PY, person-years at risk; SIR, standardized incidence ratio; CI, confidence interval; SRR, standardized rate ratio; SE, 
standard error; SSI, standard sleep interval.
a
The date of diagnosis was changed for one subject to reduce the influence of a single cell with one event and little person-
time.
bNote that this significant slope appears to be a result of a single influential cell and is highly susceptible to cutpoint 
choice.
TABLE AII
Fifteen-year Lagged Results for Exposure-related Variables, Using Quintile Cutpoints for 
Each Metric
Analysis description N cases PY SIR
95% CI 
on SIR SRR
95% CI 
on SRR Trend slope (SE), P
Absorbed dose (mGy) −1.40E-05 (3.12E-05), 0.65
 0 to <1.09 69 81,758 1.42 1.10, 1.79 1.0 —
 1.09 to <3.00 69 28,353 1.12 0.87, 1.42 0.69 0.46, 1.02
 3.00 to <5.41 68 19,374 1.52 1.18, 1.93 1.03 0.69, 1.54
 5.41to <10.7 70 19,847 1.38 1.07, 1.74 0.94 0.58, 1.53
 10.7+ 67 13,145 1.50 1.17, 1.91 0.71 0.47, 1.09
SSI travel (hours) −8.31E-08 (9.77E-08), 0.40
 0 to <208 69 84,859 1.25 0.97, 1.58 1.0 —
 208 to <599 69 26,466 1.20 0.93, 1.52 0.94 0.64, 1.38
 599 to <1146 68 18,737 1.58 1.23, 2.00 1.25 0.86, 1.83
 1146 to <2232 70 19,138 1.37 1.07, 1.73 0.93 0.64, 1.37
 2232+ 67 13,277 1.55 1.20, 1.96 0.89 0.59, 1.32
Time zones crossed (n) 2.10E-08 (6.36E-08), 0.74
 0 to <479 68 80,995 1.44 1.12, 1.83 1.0 —
 479 to <1339 70 27,756 1.16 0.90, 1.47 0.71 0.47, 1.07
 1339 to <2602 68 21,099 1.40 1.09, 1.78 0.87 0.58, 1.32
 2602 to <5046 69 19,362 1.38 1.08, 1.75 0.87 0.56, 1.36
 5046+ 68 13,266 1.53 1.19, 1.94 0.84 0.49, 1.43
Empl. duration (days) 2.29E-08 (6.68E-08), 0.73
 0 to <607 69 83,903 1.34 1.04, 1.69 1.0 —
 607 to <1338 68 26,059 1.19 0.93, 1.51 0.82 0.56, 1.20
 1338 to <2436 68 21,582 1.37 1.06, 1.73 1.04 0.69, 1.57
 2436 to <4230 69 17,687 1.49 1.16, 1.88 0.92 0.62, 1.38
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Analysis description N cases PY SIR
95% CI 
on SIR SRR
95% CI 
on SRR Trend slope (SE), P
 4230+ 69 13,247 1.51 1.17, 1.91 0.96 0.54, 1.71
PY, person-years at risk; SIR, standardized incidence ratio; CI, confidence interval; SRR, standardized rate ratio; SE, 
standard error; SSI, standard sleep interval.
TABLE AIII
Twenty-year Lagged Results for Exposure-related Variables, Using Quintile Cutpoints for 
Each Metric
Analysis description N cases PY SIR
95% CI 
on SIR SRR
95% CI 
on SRR Trend slope (SE), P
Absorbed dose (mGy) −2.19E-05 (3.96E-05), 0.58
 0 to <0.52 69 96,854 1.17 0.91, 1.48 1.0 —
 0.52 to <1.94 68 20,847 1.27 0.98, 1.61 0.77 0.44, 1.35
 1.94 to <3.94 68 17,676 1.39 1.08, 1.76 1.11 0.51, 2.40
 3.94 to <6.85 70 13,287 1.76 1.37, 2.22 0.93 0.53, 1.63
 6.85+ 68 13,813 1.39 1.08, 1.77 0.69 0.37, 1.30
SSI travel (hours) −1.23E-07 (2.26E-07), 0.59
 0 to <78.4 67 96,494 1.14 0.89, 1.45 1.0 —
 78.4 to <439.6 71 25,718 1.07 0.83, 1.35 0.79 0.44, 1.40
 439.6 to <841.3 68 14,303 1.69 1.32, 2.15 1.13 0.63, 2.03
 841.3 to <1457 69 11,879 1.91 1.49, 2.42 1.36 0.72, 2.57
 1457+ 68 14,084 1.39 1.08, 1.76 0.73 0.40, 1.32
Time zones crossed (n) 1.51E-08 (1.15E-07), 0.90
 0 to <161 69 95,509 1.22 0.95, 1.54 1.0 —
 161to <954 69 23,857 1.13 0.88, 1.43 0.65 0.37, 1.16
 954 to <1874 68 16,337 1.50 1.17, 1.90 0.84 0.46, 1.53
 1874 to <3307 69 13,444 1.71 1.33, 2.17 1.07 0.56, 2.05
 3307+ 68 13,330 1.44 1.12, 1.83 0.69 0.36, 1.32
Empl. duration (days) 4.86E-09 (7.28E-08), 0.95
 0 to <366 68 98,223 1.11 0.86, 1.41 1.0 —
 366 to <975 69 21,116 1.25 0.97, 1.59 0.80 0.43, 1.48
 975 to <1826 68 16,820 1.45 1.13, 1.84 0.89 0.48, 1.66
 1826 to <3015 69 13,337 1.72 1.34, 2.17 0.91 0.49, 1.69
 3015+ 69 12,982 1.47 1.14, 1.86 0.75 0.33, 1.58
PY, person-years at risk; SIR, standardized incidence ratio; CI, confidence interval; SRR, standardized rate ratio; SE, 
standard error; SSI, standard sleep interval.
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FIGURE 1. 
Parity (defined as live birth or still birth in the Pan Am cohort and as live birth in the U.S. 
population) in the Pan Am cohort (median year of birth 1947 interquartile range 1944–1953) 
compared to U.S. women born in 1944, 1947, and 1953 (Data for U.S. women from 
Hamilton and Cosgrove 2010).
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FIGURE 2. 
Age at first birth (AFB) (defined as age at first live birth or still birth in both the Pan Am 
cohort and in the U.S. population) in the Pan Am cohort (median year of birth 1947 
interquartile range 1944–1953) compared to U.S. women born in 1935 and 1960 (Data for 
U.S. women from Kirmeyer and Hamilton, 2011).
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TABLE I
Cohort Characteristics
Characteristic Questionnaire respondents Breast cancer cases
Number 6093 344
Age at end of follow-up for breast cancera
 Median 55.2 51.3
 IQ range 48.6–59.0 46.3–56.3
Year of birth
 Median 1947 1944
 IQ range 1944–1953 1939–1947
Vital statusb
 Alive 5972 (98%) 315 (92%)
 Deceased 121 (2%) 29 (8%)
Race
 White 5568 (91%) 322 (94%)
 All other races 525 (9%) 22 (6%)
Family history of breast cancer
 No 5062 (83%) 256 (74%)
 Yes 846 (14%) 71 (21%)
 Unknown 185 (3%) 17 (5%)
Parityc
 None 2125 (35%) 124 (36%)
 1 1162 (19%) 63 (18%)
 2 1846 (30%) 111 (32%)
 3+ 884 (15%) 42 (12%)
 Unknown 76 (1%) 4 (1%)
Age at first birthd
 <25 380 (10%) 17 (8%)
 25–29 1455 (37%) 93 (43%)
 30–34 1293 (33%) 65 (30%)
 35+ 764 (20%) 41 (19%)
Cumulative absorbed radiation dose (mGy)
 Median (IQ range) 7.2 (2.7–17) 5.5 (2.6–16)
 Mean (std dev) 12 (11) 10 (10)
Cumulative number of time zones crossed
 Median (IQ range) 3600 (1300–8600) 2700 (1200–7400)
 Mean (std dev) 5800 (5900) 5000 (5200)
Cumulative hours flying in the standard sleep interval
 Median (IQ range) 1500 (510–3200) 1300 (520–3000)
 Mean (std dev) 2200 (2200) 2000 (2000)
Cumulative employment duration (years)
 Median (IQ range) 7.7 (3.1–17) 6.8 (3.1–16)
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Characteristic Questionnaire respondents Breast cancer cases
 Mean (std dev) 12 (10) 11 (10)
IQ, interquartile.
a
Defined as the age at the earliest of: date of first breast cancer diagnosis, date of interview (for living subjects), and date of death (for decedents).
bAt questionnaire completion.
cNumber of live or still births.
dAmong participants with one or more live or still births.
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TABLE II
Standardized Incidence Ratios of Breast Cancer for Women in Overall Pan Am Cohort (n = 6092a) and for 
Covariates of Interest
Analysis description Person-years SIR 95% CI
Overall cohorta 162,477 1.37 1.23, 1.52
Race
 White 149,064 1.37 1.23, 1.53
 All other races 13,414 1.31 0.82, 1.98
Family history of breast cancer
 No 134,104 1.25 1.11, 1.42
 Yes 23,547 1.89 1.47, 2.38
 Unknown 4826 2.02 1.18, 3.23
Parityb,c
 0 76,121 1.35 1.12, 1.60
 1 29,458 1.38 1.06, 1.76
 2 37,232 1.58 1.30, 1.90
 3+ 17,725 1.05 0.75, 1.42
Age at first birthc
 <25 9856 1.03 0.60, 1.65
 25–29 37,008 1.44 1.16, 1.77
 30–34 26,105 1.34 1.03, 1.70
 35+ 11,446 1.56 1.12, 2.12
SIR, standardized incidence ratio, adjusted for age, race and calendar year; CI, confidence interval.
aOne woman was excluded from the cohort because she had a breast cancer diagnosis before the rate begin date.
b
Parity indicates number of live or still births.
c76 women, including 4 breast cancer cases, were excluded due to missing parity and age at first birth.
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TABLE IV
Effect Modification of Trend Slopea for 10-Year Lagged Exposure Variables, by Family History
Family history
Absorbed dose (mGy) 
slope (SE)
Hours flying in standard 
sleep interval slope (SE)
Time zones crossed slope 
(SE)
Employment duration 
(days) slope (SE)
Yes −1.15E-05 (2.17E-05) −2.32E-07 (2.21E-07) −6.28E-08 (4.51E-08) −8.86E-08 (1.17E-07)
No −1.05E-05 (1.04E-05) −5.01E-09 (7.24E-08) −9.42E-09 (2.13E-08) −4.84E-09 (5.39E-08)
Pooled estimateb −1.07E-05 −2.69E-08 −1.92E-08 −1.94E-08
Unadjusted estimate −1.05E-05 (8.27E-06) −4.34E-08 (9.39E-08) −1.63E-08 (1.98E-08) −2.07E-08 (5.43E-08)
SE, standard error.
aSlope units are breast cancers per person-year · exposure unit.
b
Inverse-variance weighted.
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TABLE V
Effect Modification of Trend Slopea for 10-Year Lagged Exposure Variables, by Parity.
Parity (number of 
births)
Absorbed dose (mGy) 
slope (SE)
Hours flying in standard 
sleep interval slope (SE)
Time zones crossed slope 
(SE)
Employment duration 
(days) slope (SE)
0 −2.95E-05 (1.75E-05) 9.93E-09 (1.55E-07) −6.74E-08 (3.48E-08) −6.24E-08 (6.87E-08)
1
−3.90E-05* (1.37E-05) −4.65E-08 (2.50E-07) −7.43E-08* (2.88E-08) −5.89E-08 (7.86E-08)
2 2.17E-05 (6.39E-05) 1.52E-07 (2.74E-07) 9.98E-08 (1.31E-07) 6.15E-09 (5.39E-08)
3+ 2.62E-04** (1.23E-04) 7.00E-07** (2.89E-07) 6.22E-07** (2.53E-07) 5.11E-07 (4.88E-07)
Pooled estimateb NR NR NR NR
Unadjusted estimate −1.71E-05 (1.20E-05) −4.07E-08 (1.05E-07) −2.52E-08 (2.81E-08) −3.90E-08 (4.77E-08)
SE, standard error; NR, a pooled estimate is not reported given the strong apparent effect modification.
aSlope units are breast cancers per person-year · exposure unit.
b
Inverse-variance weighted.
*
P <0.01.
**
P <0.05.
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TABLE VI
Effect Modification of Trend Slope for 10-year Lagged Exposure Variables, by Age at First Birth
Age at first birth
Absorbed dose (mGy) 
slope (SE)
Hours flying in 
standard sleep interval 
(SE)
Time zones crossed slope 
(SE)
Employment duration 
(days) slope (SE)
14–<25 1.02E-05 (8.00E-05) Not reportedb 2.18E-07** (1.01E-07) −1.29E-08 (2.08E-07)
25–<30 4.42E-05 (1.00E-04) 2.58E-09 (4.22E-07) 1.44E-07 (1.86E-07) −2.51E-07 (2.45E-07)
30–<35
−7.83E-05** (3.41E-05) −2.83E-08 (2.12E-07) −1.07E-07 (6.98E-08) −4.17E-09 (7.14E-08)
35+ −2.39E-05 (5.06E-05) −6.13E-08 (1.65E-07) −3.16E-08 (1.18E-07)
−1.70E-07** (8.39E-08)
Pooled estimatea NR NR NR −7.80E-08
Unadjusted estimate 3.94E-05 (3.53E-05) 1.57E-07 (2.13E-07) 8.86E-08 (6.73E-08) 6.38E-08 (7.47E-08)
SE, standard error; NR, a pooled estimate not reported given the strong apparent effect modification.
a
Inverse-variance weighted.
b
Zero-cells present in one exposure category.
**
P <0.05.
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